SCHEMBL22097007

SCHEMBL22097007

c1ccc(-c2nc(-c3ccc(-c4cccnc4)cc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4cc6c(cc54)sc4ccccc46)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.42
CYP19A1 P11511 2/20 0.42
CYP11B2 P19099 2/20 0.42
CYP17A1 P05093 1/20 0.42
PIK3CD O00329 1/20 0.41
PIP5K1C O60331 1/20 0.41
PIK3CA P42336 1/20 0.41
PI4KA P42356 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
LIMK1 P53667 1/20 0.41
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
ALDH1A1 P00352 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
GLA P06280 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097235 1.00 CYP11B1 (0.42) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL22097073 0.98 CYP1A2 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL22096966 0.98 CYP1A2 (0.40) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL19166781 0.92 CYP11B1 (0.47) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL22097135 0.89 CYP19A1 (0.52) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL22097126 0.89 CYP19A1 (0.52) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL19166686 0.88 PIK3CA (0.45) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL19166668 0.88 CYP11B1 (0.43) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL19165456 0.88 CYP11B1 (0.43) CYP11B1CYP19A1CYP11B2CYP17A1PIK3CD
SCHEMBL22097161 0.88 MAPT (0.41) PIK3CAPI4KAPI4KBLIMK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 CYP11B1 1062/4885CYP19A1 2111/4885CYP11B2 923/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 CYP11B1 1062/4885CYP19A1 2111/4885CYP11B2 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.